ReGen III Corp.
ReGen III Corp. (ISRJF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for ReGen III Corp. (ISRJF), covering cash flow, earnings, and balance sheets.
ReGen III Corp. (ISRJF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for ReGen III Corp. ISRJF financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $16513.00 | $16513.00 | $16513.00 |
| Gross Profit | $0.00 | -$16513.00 | -$16513.00 | -$16513.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $64084.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $551425.00 | $622902.00 | $970336.00 | $1.27M |
| Operating Expenses | $615509.00 | $875582.00 | $970336.00 | $1.27M |
| Total Costs & Expenses | $615509.00 | $892095.00 | $986849.00 | $1.29M |
| Interest Income | $0.00 | $6986.00 | $11690.00 | $25028.00 |
| Interest Expense | $0.00 | $148902.00 | $123974.00 | $116370.00 |
| Depreciation & Amortization | $5504.00 | $16513.00 | $16513.00 | $16513.00 |
| EBITDA | -$615509.00 | -$1.05M | -$911903.00 | -$1.40M |
| EBITDA Ratio | $0.00 | |||
| Operating Income | -$615509.00 | -$892095.00 | -$935484.00 | -$1.29M |
| Operating Income Ratio | $0.00 | |||
| Other Income/Expenses (Net) | $624934.00 | -$319873.00 | -$116907.00 | -$293219.00 |
| Income Before Tax | $9425.00 | -$1.21M | -$1.05M | -$1.53M |
| Income Before Tax Ratio | $0.00 | |||
| Income Tax Expense | $28095.00 | -$24427.00 | -$53823.00 | -$3.00 |
| Net Income | -$18670.00 | -$1.19M | -$998568.00 | -$1.53M |
| Net Income Ratio | $0.00 | |||
| EPS | -$0.00 | -$0.01 | -$0.008 | -$0.01 |
| Diluted EPS | -$0.00 | -$0.01 | -$0.008 | -$0.01 |
| Weighted Avg Shares Outstanding | $122.03M | $118.36M | $118.36M | $118.36M |
| Weighted Avg Shares Outstanding (Diluted) | $121.25M | $118.36M | $118.36M | $118.36M |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Gross profit remained healthy with margins at N/A in Q4 2024 compared to N/A in Q1 2024. Operating income hit -$615509.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$615509.00. Net income rose to -$18670.00, while earnings per share reached -$0.00. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan